
Hannah Joseph Hospital Limited is a multi-speciality healthcare provider established in 2008 in Madurai, Tamil Nadu. Operating on a two-acre campus, the hospital has a capacity of 150 beds and specializes in neurosurgery, neurology, cardiology, psychiatry, and trauma care. Led by its founders, Mosesjoseph Arunkumar and Fenn Kavitha Fenn Arunkumar, the hospital has gained recognition for handling complex surgeries and is accredited by both NABH and NABL. It has expanded its services to include a cardiac sciences department with a Cath lab and performs complex coronary angioplasties and open-heart surgeries, establishing itself as a key healthcare institution in South Tamil Nadu.
Jan 22, 2026
Jan 27, 2026
Jan 30, 2026
SME
Closed
42 Cr
42 Cr
0 Cr
₹67 - ₹70
2000
The main objectives of the issue are to utilize the net proceeds for the following purposes:
Funding the capital expenditure required for establishing a state-of-the-art Radiation Oncology Centre. This includes the construction of a new building, covering structures, civil and interior works, and MEP services, as well as the procurement of advanced medical equipment such as a medical linear accelerator (LINAC) and other ancillary devices for radiation therapy.
To meet general corporate purposes which include, but are not restricted to, meeting operating expenses, funding initial development costs for new projects, strengthening business development and marketing capabilities, and addressing unforeseen business exigencies, subject to the amount not exceeding 15% of the gross proceeds or ₹10 crore, whichever is less.
16.21
4.32
9.39%
10.41%
9.62%
—
12.03%
27.38%
2.2
High reputation for providing quality health and wellness.
Headed by a prominent Neurosurgeon.
Specialized imported surgical equipment on par with major corporate hospitals.
High consistency and success rates in handling complicated surgeries.
Limited geographical presence, with operations concentrated in a single location.
Significant financial needs for acquiring and updating high-cost medical equipment.
Challenges in expanding from a specialty focus to a multi-speciality hospital model.
Exploring expansion by setting up branches in Tier II & III cities.
Diversification into other specializations like Radiation therapy and Oncological services.
Collaborating with other healthcare organizations for knowledge sharing and partnerships.
Leveraging technological advancements to enhance medical services and operational efficiency.
Potential shortages of skilled medical and paramedical manpower.
Increasing pressure to reduce costs while meeting expectations for universal healthcare coverage.
Challenges in managing effective budgets amidst rising operational costs.
Navigating complex and evolving regulatory compliance in the healthcare sector.
Hannah Joseph Hospital Limited is a multi-speciality healthcare provider established in 2008 in Madurai, Tamil Nadu. Operating on a two-acre campus, the hospital has a capacity of 150 beds and specializes in neurosurgery, neurology, cardiology, psychiatry, and trauma care. Led by its founders, Mosesjoseph Arunkumar and Fenn Kavitha Fenn Arunkumar, the hospital has gained recognition for handling complex surgeries and is accredited by both NABH and NABL. It has expanded its services to include a cardiac sciences department with a Cath lab and performs complex coronary angioplasties and open-heart surgeries, establishing itself as a key healthcare institution in South Tamil Nadu.
The Hannah Joseph Hospital Ltd. IPO is scheduled to open for subscription on Jan 22, 2026 and close on Jan 27, 2026. Investors can apply for shares during this period through eligible platforms.
The price band for the Hannah Joseph Hospital Ltd. IPO is ₹67 to ₹70. Investors can place bids within this range once the issue opens.
The minimum lot size for the Hannah Joseph Hospital Ltd. IPO is 2000 shares. The minimum investment amount ₹1,40,000.
The total issue size of the Hannah Joseph Hospital Ltd. IPO is approximately ₹42.00. Issue size represents the total value of shares offered to the public.
As per the latest available information, the Hannah Joseph Hospital Ltd. IPO has been subscribed 0.51 times. Subscription levels can change significantly during the offer period.
The Grey Market Premium (GMP) for the Hannah Joseph Hospital Ltd. IPO is not available as of now. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
The shares of Hannah Joseph Hospital Ltd. are expected to list on stock exchanges on Jan 30, 2026, subject to completion of the allotment process and regulatory approvals.
The net proceeds from the Hannah Joseph Hospital Ltd. IPO are proposed to be used for The main objectives of the issue are to utilize the net proceeds for the following purposes:, Funding the capital expenditure required for establishing a state-of-the-art Radiation Oncology Centre. This includes the construction of a new building, covering structures, civil and interior works, and MEP services, as well as the procurement of advanced medical equipment such as a medical linear accelerator (LINAC) and other ancillary devices for radiation therapy., To meet general corporate purposes which include, but are not restricted to, meeting operating expenses, funding initial development costs for new projects, strengthening business development and marketing capabilities, and addressing unforeseen business exigencies, subject to the amount not exceeding 15% of the gross proceeds or ₹10 crore, whichever is less.
Before applying for the Hannah Joseph Hospital Ltd. IPO, investors generally review the company’s business model, financial performance, valuation, industry outlook, and risk factors mentioned in the offer document.